Santa Clara chipmaker Intel and the Michael J. Fox Foundation announced a partnership Wednesday to find new ways to treat victims of Parkinson’s disease, the widespread neurodegenerative brain disorder.
The collaboration will include analyzing data gathered from gadgets worn by Parkinson’s patients to monitor their sleep quality, tremors, slowness of movement and other symptoms, the company and the foundation said in a press release.
“Nearly 200 years after Parkinson’s disease was first described by Dr. James Parkinson in 1817, we are still subjectively measuring Parkinson’s disease largely the same way doctors did then,” said Todd Sherer, CEO of The Michael J. Fox Foundation in the release. “Data science and wearable computing hold the potential to transform our ability to capture and objectively measure patients’ actual experience of disease, with unprecedented implications for Parkinson’s drug development, diagnosis and treatment.”
Photo by Paul Sakuma, Associated Press